de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

A new study highlights the link between inflammation and depression, challenging traditional neurotransmitter-focused ...

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier this year, this ...

Transmagnetic stimulation (TMS) is an FDA-approved noninvasive neurostimulation intervention used to treat TRD. TMS delivers ...

Kabir Nigam [Opens in a new window], Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for ...

While Rejoyn is approved for depression, "it is not designed as a standalone treatment," says King; the approval is as a supplement to existing treatments or therapy to improve their effectiveness.

“Particularly in the postpartum period, there’s a lot of anxiety and irritability, plus lack of sleep, which is a huge risk factor for postpartum depression.” And while it’s not necessarily a symptom ...

Then, they can use them with the features of Invisalign Smile Architect to develop a personalized treatment plan. The new software from Align integrates with its digital platform, a combination of ...

HOUSTON — A new breakthrough in depression treatment may soon provide mental health relief from the comfort of your own couch. Researchers have found that a device delivering mild electrical ...

In this review, we discuss, first, the development of the two most commonly studied constructs, burnout and depression ... physicians from seeking treatment for mental health or substance use ...

The stakes are high for psilocybin clinical trials — there’s a pressing need for a more effective medical solution in the fight against depression, especially treatment-resistant depression.